Rutika Mehta, GI Medical Oncologist and Associate Professor at Weill Cornell Medicine, shared a post on X about a paper she co-authored with colleagues published in Cancer:
“Just published.
Multi-institutional study of the utility of tumor-informed MRD in advanced GECs
MRD testing is feasible, and dynamics is prognostics. What should be next for ctDNA to help move the needle?”
Title: Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers
Authors: Rutika Mehta, Samuel Rivero-Hinojosa, Farshid Dayyani, Jenifer Ferguson, Bushra Shariff, Vasily N. Aushev, Griffin L. Budde, J. Bryce Ortiz, Giby V. George, Shruti Sharma, Adham A. Jurdi, Minetta C. Liu, Ronald L. Drengler, and Samuel J. Klempner.
You can read the Full Article in Cancer.
More posts featuring Rutika Mehta.